Sugi Predict

Sugi Predict / Compounds / Guaiacol

Guaiacol

Guaiacol

SCHEMBL249368

C(OCC1CO1)C1CO1.COc1ccccc1O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA2 P00918 2/20 0.58
▸ TSHR P16473 2/20 0.58
▸ ALDH1A1 P00352 3/20 0.50
▸ GLA P06280 1/20 0.50
▸ PPARD Q03181 4/20 0.45
▸ PPARG P37231 3/20 0.45
▸ PTPN1 P18031 2/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ CYP3A4 P08684 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894129 0.87 ALDH1A1 (0.49) TP53CA1CA2TSHRALDH1A1
Catechol SCHEMBL679936 0.84 TDP1 (0.52) TP53CA2TSHRALDH1A1GLA
Orthocresol SCHEMBL1287877 0.81 ALDH1A1 (0.54) TP53TSHRALDH1A1GLAPPARG
SCHEMBL20530996 0.81 MAOB (0.61) PPARDPPARGPTPN1ALOX5CYP3A4
SCHEMBL27934586 0.80 PPARG (0.49) PPARDPPARGPTPN1ALOX5CYP3A4
Ethane SCHEMBL9175082 0.80 ALDH1A1 (0.67) TP53CA1CA2TSHRALDH1A1
SCHEMBL394006 0.80 TDP1 (0.47) TP53TSHRALDH1A1GLACYP3A4
SCHEMBL3858634 0.80 ALDH1A1 (0.66) TP53CA1CA2TSHRALDH1A1
Propane SCHEMBL8617536 0.79 ALDH1A1 (0.65) TP53CA1CA2TSHRALDH1A1
SCHEMBL28659992 0.79 ALDH1A1 (0.55) TSHRALDH1A1GLACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111440131-B Method for refining easy-to-decompose guaiacol glycidyl ether 江苏惠利生物科技有限公司 2021-12-28 — — CN claimed
CN-111440131-A Method for refining easy-to-decompose guaiacol glycidyl ether 江苏惠利生物科技有限公司 2020-07-24 — — CN claimed
CN-106957426-B A kind of functional resin and preparation method thereof promoting cation-type water-thinned anticorrosion with coat covering power 浩力森化学科技（江苏）有限公司 2019-01-25 — — CN claimed
CN-106957426-A A kind of functional resin for lifting cation-type water-thinned anticorrosion with coat covering power and preparation method thereof 浩力森化学科技（江苏）有限公司 2017-07-18 — — CN claimed
CN-104356372-B A kind of cladodification aliphatic-aromatic copolyester and synthetic method thereof 清华大学 2016-10-26 — — CN claimed
WO-2016065576-A1 PROCESS FOR PREPARATION OF HIGH PURITY GUAIACOL GLYCIDYL ETHER TIANJIN WEIJIE PHARMACEUTICAL CO., LTD. (CN) 2016-05-06 — — WO claimed
CN-103113563-B A kind of cladodification aliphatic polyester and synthetic method thereof TSINGHUA UNIVERSITY (CN) 2015-08-19 — — CN claimed
CN-101838249-B A kind of method preparing high-purity guaiacol glycidyl ether ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2015-08-19 — — CN claimed
CN-104356372-A Cladodified fat-aromatic copolyester and synthesis method thereof UNIV TSINGHUA 2015-02-18 — — CN claimed
CN-103113563-A Branched aliphatic polyester and synthetic method thereof UNIV TSINGHUA 2013-05-22 — — CN claimed
CN-101838249-A Method for preparing high-purity guaiacol glycidyl ether ZHEJIANG HUAHAI PHARM CO LTD 2010-09-22 — — CN claimed
EP-4747296-A1 ADHESIVE WITH IMPROVED ADHESION ON EPOXY RESIN ADHESIVE REMNANTS Sika Technology AG (CH) 2026-05-27 — — EP disclosed
US-20260078214-A1 CURING AGENT FOR EPOXY RESINS, WHICH CURING AGENT HAS DIPHENOLIC ACID SIKA TECHNOLOGY AG (CH) 2026-03-19 — — US disclosed
US-12528905-B2 Amine-epoxy resin addition product SIKA TECHNOLOGY AG (CH) 2026-01-20 — — US disclosed
US-12516148-B2 Amine epoxy resin adduct SIKA TECHNOLOGY AG (CH) 2026-01-06 — — US disclosed
WO-2012003392-A1 FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS GILEAD SCIENCES, INC. (US) 2012-01-05 — — WO disclosed
WO-2011113228-A1 A PROCESS FOR PREPARING GUAIACOL GLYCIDYL 浙江华海药业股份有限公司 (CN) 2011-09-22 — — WO disclosed
CN-101838249-A Method for preparing high-purity guaiacol glycidyl ether ZHEJIANG HUAHAI PHARM CO LTD 2010-09-22 — — CN disclosed
CN-101838249-A Method for preparing high-purity guaiacol glycidyl ether ZHEJIANG HUAHAI PHARM CO LTD 2010-09-22 — — CN disclosed
CN-101838249-A Method for preparing high-purity guaiacol glycidyl ether ZHEJIANG HUAHAI PHARM CO LTD 2010-09-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078214-A1 CURING AGENT FOR EPOXY RESINS, WHICH CURING AGENT HAS DIPHENOLIC ACID PTGER1, DDAH1, MEP1A TP53 3623/4885CA1 994/4885CA2 1660/4885
US-12528905-B2 Amine-epoxy resin addition product RAD51, PTGER1, APEX1 TP53 3536/4885CA1 2480/4885CA2 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.